Singapore markets closed

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
20.35-0.23 (-1.12%)
At close: 04:00PM EDT
20.35 0.00 (0.00%)
After hours: 06:39PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close20.58
Open20.47
Bid20.32 x 100
Ask20.38 x 100
Day's range20.03 - 20.53
52-week range19.88 - 44.09
Volume308,788
Avg. volume218,657
Market cap608.479M
Beta (5Y monthly)1.42
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024

    EL MONTE, Calif., April 11, 2024--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its first quarter 2024 financial results before the market opens on Friday, May 3, 2024. Management will host a conference call for the investment community the same day at 8:30 AM ET (5:30 AM PT) to discuss the results and answer questions.

  • Business Wire

    Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results

    EL MONTE, Calif., February 28, 2024--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its fourth quarter and full year ended December 31, 2023.

  • Business Wire

    Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024

    EL MONTE, Calif., February 13, 2024--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that it will release its fourth quarter and full year 2023 financial results before the market opens on Wednesday, February 28, 2024. Management will host a conference call for the investment community the same day at 8:30 AM ET (5:30 AM PT) to discuss the re